These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


395 related items for PubMed ID: 20826675

  • 1. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.
    Goussakov I, Miller MB, Stutzmann GE.
    J Neurosci; 2010 Sep 08; 30(36):12128-37. PubMed ID: 20826675
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice.
    Chakroborty S, Kim J, Schneider C, West AR, Stutzmann GE.
    J Neurosci; 2015 Apr 29; 35(17):6893-902. PubMed ID: 25926464
    [Abstract] [Full Text] [Related]

  • 3. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I, Holmgren C, Min R, Fülöp L, Zilberter M, Sousa KM, Farkas T, Härtig W, Penke B, Burnashev N, Tanila H, Zilberter Y, Harkany T.
    Eur J Neurosci; 2006 Apr 29; 23(8):2035-47. PubMed ID: 16630051
    [Abstract] [Full Text] [Related]

  • 4. Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice.
    Chakroborty S, Goussakov I, Miller MB, Stutzmann GE.
    J Neurosci; 2009 Jul 29; 29(30):9458-70. PubMed ID: 19641109
    [Abstract] [Full Text] [Related]

  • 5. Generation of dendritic Ca2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons.
    Goussakov I, Chakroborty S, Stutzmann GE.
    Channels (Austin); 2011 Jul 29; 5(1):9-13. PubMed ID: 21139422
    [Abstract] [Full Text] [Related]

  • 6. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK, Jacobi E, Sakimura K, Malinow R, von Engelhardt J.
    Acta Neuropathol Commun; 2018 Oct 23; 6(1):110. PubMed ID: 30352630
    [Abstract] [Full Text] [Related]

  • 7. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B, Del Prete D, Greco B, Zhang X, Lauritzen I, Sevalle J, Moreno S, Paterlini-Bréchot P, Trebak M, Checler F, Benfenati F, Chami M.
    J Neurosci; 2012 Aug 22; 32(34):11820-34. PubMed ID: 22915123
    [Abstract] [Full Text] [Related]

  • 8. Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice.
    Chakroborty S, Kim J, Schneider C, Jacobson C, Molgó J, Stutzmann GE.
    J Neurosci; 2012 Jun 13; 32(24):8341-53. PubMed ID: 22699914
    [Abstract] [Full Text] [Related]

  • 9. Calcium from internal stores triggers GABA release from retinal amacrine cells.
    Warrier A, Borges S, Dalcino D, Walters C, Wilson M.
    J Neurophysiol; 2005 Dec 13; 94(6):4196-208. PubMed ID: 16293593
    [Abstract] [Full Text] [Related]

  • 10. The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.
    Liu D, Pitta M, Lee JH, Ray B, Lahiri DK, Furukawa K, Mughal M, Jiang H, Villarreal J, Cutler RG, Greig NH, Mattson MP.
    J Alzheimers Dis; 2010 Dec 13; 22(2):443-57. PubMed ID: 20847430
    [Abstract] [Full Text] [Related]

  • 11. Glutamate spillover promotes the generation of NMDA spikes.
    Chalifoux JR, Carter AG.
    J Neurosci; 2011 Nov 09; 31(45):16435-46. PubMed ID: 22072693
    [Abstract] [Full Text] [Related]

  • 12. Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease.
    Chakroborty S, Briggs C, Miller MB, Goussakov I, Schneider C, Kim J, Wicks J, Richardson JC, Conklin V, Cameransi BG, Stutzmann GE.
    PLoS One; 2012 Nov 09; 7(12):e52056. PubMed ID: 23284867
    [Abstract] [Full Text] [Related]

  • 13. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models.
    Stutzmann GE, Smith I, Caccamo A, Oddo S, Parker I, Laferla F.
    Ann N Y Acad Sci; 2007 Feb 09; 1097():265-77. PubMed ID: 17413028
    [Abstract] [Full Text] [Related]

  • 14. BDNF enhances dendritic Ca2+ signals evoked by coincident EPSPs and back-propagating action potentials in CA1 pyramidal neurons.
    Pozzo-Miller L.
    Brain Res; 2006 Aug 09; 1104(1):45-54. PubMed ID: 16797499
    [Abstract] [Full Text] [Related]

  • 15. β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice.
    Briggs CA, Schneider C, Richardson JC, Stutzmann GE.
    Neurobiol Aging; 2013 Jun 09; 34(6):1632-43. PubMed ID: 23337342
    [Abstract] [Full Text] [Related]

  • 16. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
    Bories C, Arsenault D, Lemire M, Tremblay C, De Koninck Y, Calon F.
    Aging (Albany NY); 2017 May 16; 9(5):1386-1403. PubMed ID: 28522792
    [Abstract] [Full Text] [Related]

  • 17. NMDA receptor-mediated subthreshold Ca(2+) signals in spines of hippocampal neurons.
    Kovalchuk Y, Eilers J, Lisman J, Konnerth A.
    J Neurosci; 2000 Mar 01; 20(5):1791-9. PubMed ID: 10684880
    [Abstract] [Full Text] [Related]

  • 18. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.
    Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I.
    J Neurosci; 2006 May 10; 26(19):5180-9. PubMed ID: 16687509
    [Abstract] [Full Text] [Related]

  • 19. Estradiol increases spine density and NMDA-dependent Ca2+ transients in spines of CA1 pyramidal neurons from hippocampal slices.
    Pozzo-Miller LD, Inoue T, Murphy DD.
    J Neurophysiol; 1999 Mar 10; 81(3):1404-11. PubMed ID: 10085365
    [Abstract] [Full Text] [Related]

  • 20. Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
    Ruiter M, Herstel LJ, Wierenga CJ.
    J Alzheimers Dis; 2020 Mar 10; 78(3):951-964. PubMed ID: 33074225
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.